
Please try another search
hVIVO plc, formerly Open Orphan plc, is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. It provides end-to-end early clinical development services to its client base, which includes global biopharma companies. It offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. It offers additional clinical field trial services, such as patient recruitment and clinical trial site services. It runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.
Name | Age | Since | Title |
---|---|---|---|
Elaine Sullivan | 60 | 2020 | Independent Non-Executive Director |
John Oxford | - | 2020 | Chair of Advisory Board |
Michael Meade | 60 | 2020 | Independent Non-Executive Director |
Brendan Buckley | 71 | - | Member of Advisory Board & Non-Executive Director |
Martin John Gouldstone | 55 | 2022 | Independent Non-Executive Director |
Cathal Martin Friel | 57 | 2020 | Non-Executive Chairman |
Yamin Mohammed Khan | 52 | 2021 | CEO & Director |
Stephen Pinkerton | - | 2022 | CFO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review